- Case Report
- Open access
- Published:
Myocardial ischemia caused by the synergistic effect of myocardial bridge and moderate stenosis: case report
BMC Cardiovascular Disorders volume 24, Article number: 412 (2024)
Abstract
Background
Clinical events such as angina pectoris, acute coronary syndrome, and sudden death caused by myocardial bridge (MB) have attracted increasing attention. It is still a challenge to diagnose whether MB can cause the symptoms of patients with MB. For most MB patients, medication remains the primary treatment.
Case presentation
This article reports a case of chest pain in a patient with MB in the middle segment of the left anterior descending artery (LADm) with moderate stenosis in the proximal segment (LADp). Through functional assessment, we found that neither MB nor fixed stenosis had sufficient effect on coronary blood flow to cause myocardial ischemia, but their synergistic effect resulted in myocardial ischemia. Finally, a stent was implanted in LADp and good clinical results were achieved.
Conclusions
For symptomatic patients with MB combined with fixed stenosis, functional evaluation may be necessary, which has significant guiding significance for treatment strategy selection. For asymptomatic patients, early detection of myocardial ischemia may also improve the prognosis of patients.
Introduction
MB is a congenital anatomic abnormality, but it can be associated with a range of serious cardiac events, such as coronary artery spasm [1], angina [2], arrhythmia [3, 4], myocardial infarction [5], and sudden cardiac death [6]. MB is identified as an independent predictor of myocardial infarction with non-obstructive coronary artery [7]. An increased incidence of major adverse cardiovascular events and myocardial ischemia has been observed in patients with MB [8]. Most patients with MB have no obvious clinical symptoms. To date, the etiological diagnosis of myocardial ischemia in patients with MB remains challenging. (1) Directly related to MB; (2) Indirect correlation with coronary artery spasm; (3) It is associated with atherosclerotic coronary artery disease; (4) Clinically unrelated to MB [9, 10]. Unlike the fixed stenosis produced by atherosclerotic plaques, dynamic stenosis caused by MB compression of coronary arteries varies with changes in heart cycle, heart rate, and sympathetic tone. When both exist simultaneously, their effects on distal coronary perfusion are still uncertain, and there is no unified guideline to guide the treatment [11]. For symptomatic MB patients, medical therapy remains the preferred recommended method, and percutaneous coronary intervention or surgery may be considered if ineffective [10]. In this case, we found that myocardial ischemia was caused by the synergistic effect of myocardial bridge and moderate stenosis through functional assessment. The patient’s chest pain was relieved after stent implantation in the stenosis. In the clinic, physicians should be cautious in the management of patients with MB and fixed stenosis.
Case report
The patient is a 58-year-old male. He had a smoking history of 40 years. He has had hypertension for 7 years, up to 160/110mmHg. His blood pressure was controlled well with perindopril indapamide tablets. He had been diabetic for 23 years and was treated with daily subcutaneous injections of aspartate 30 insulin. His blood glucose control result was unknown (not systematically tested). He complained of chest pain with no obvious cause 5 years ago, located in the precardiac region, radiating back for a few seconds, resolved with rest, and no systemic treatment was performed. Three years ago, he was treated in a Chinese medicine clinic and intermittently took Chinese medicine for a year (the details are unknown), but his symptoms still recurred. In the past half month, the above symptoms worsened and accompanied by palpitations, and dizziness. He went to the Shenyang Central Hospital, where he was treated with metoprolol succinate, aspirin, and atorvastatin calcium, but his symptoms were not significantly relieved. The patient’s physical examination showed no abnormality. The patient had no family history of the disease. The patient’s ECG on admission showed sporadic premature ventricular beats (Fig. 1). In addition to the high blood glucose test results, other laboratory tests and cardiac ultrasonography showed no abnormality.
To determine the cause, coronary angiography and intravascular ultrasound (Fig. 2) were performed. LADp showed moderate stenosis, and LADm showed myocardial bridging (Supporting information: Video 1). Before implantation of a stent in LADp (Fig. 3A), functional assessment showed the coronary fractional flow reserve (FFR) values of coronary artery opening, proximal and distal to the MB were 1.0 (FFRa1), 0.90 (Fig. 3B, FFRa2), and 0.77 (Fig. 3C, FFRa3), respectively. The diastolic fractional flow reserve (dFFR) values of proximal and distal to the MB were 0.85 (dFFRa2) and 0.70 (dFFRa3), respectively. The fractional flow reserve gradient (ΔFFR) value at the stenosis was 0.10 (ΔFFR1, FFRa1-FFRa2). The diastolic fractional flow reserve gradient(ΔdFFR) value of the MB was 0.15 (ΔdFFR1, dFFRa2-dFFRa3). After implantation of a stent in LADp (Fig. 3D), the FFR values of coronary artery opening, proximal and distal to the MB were 0.99 (FFRb1), 0.97 (Fig. 3E, FFRb2), and 0.89 (Fig. 3F, FFRb3), respectively; The dFFR values of proximal and distal to the MB were 0.96 (dFFRb2) and 0.86(dFFRb3), respectively. The ΔFFR2 (FFRb1-FFRb2) value was 0.02, and the ΔdFFR2 (dFFRb2-dFFRb3) value was 0.10. After stent implantation, the patient’s chest pain was significantly improved. The patient has been discharged for about half a year. In a recent outpatient follow-up, the patient had a good prognosis.
Results of functional assessment. (A) Before stent implantation, the FFR was 1.0, 0.90, 0.77 at coronary opening, proximal MB and distal MB; the dFFR was 0.85, 0.70 at proximal MB and distal MB; (B) The FFR result at proximal MB before stent implantation; (C) The FFR result at distal MB before stent implantation; (D) After stent implantation, the FFR was 0.99, 0.97, 0.89 at coronary opening, proximal MB and distal MB; the dFFR was 0.96, 0.86 at proximal MB and distal MB; (E) The FFR result at proximal MB after stent implantation; (F) The FFR result at distal MB after stent implantation
Discussion
In this case, we performed a functional assessment of fixed stenosis and MB by FFR, dFFR, ΔFFR, and ΔdFFR. The “FFR ≤ 0.80” and “ΔFFR ≥ 0.2 (1-0.8)” were used as the cut-off value for ischemia due to fixed stenosis [10]. The “dFFR ≤ 0.76” and “ΔdFFR ≥ 0.24 (1-0.76) " are the cut-off value for functional evaluation of MB [12]. Before stent implantation, ΔFFR1 value was 0.10(< 0.20), and ΔdFFR1 value was 0.15(< 0.24), indicating that neither fixed stenosis nor MB was sufficient to cause myocardial ischemia. However, FFRa3=0.77 and dFFRa3=0.70 indicated distal myocardial ischemia in the LAD. Combined with the patient’s typical angina symptoms and functional evaluation results, a stent was implanted to the fixed stenosis. After stent implantation, the FFRb3 value was 0.89 and the dFFRb3 was 0.86. Nearly half a year follow-up, the patient’s clinical symptoms improved significantly.
Currently, there is no uniform clinical guidance for the treatment of MB. It is mainly based on case reports and expert opinion and also involves decisions made by individual clinicians [11]. For symptomatic MB patients, β-blockers and non-dihydropyridine calcium channel blockers are routinely used as first-line medical therapy. For patients who cannot tolerate β-blockers and calcium channel blockers, ivabradine is a second-line option for pharmacotherapy [13]. For patients with refractory symptoms, invasive treatment strategies such as percutaneous coronary intervention and cardiac surgery may be considered [10]. However, percutaneous coronary intervention within MB has limited efficacy in addressing ischemic symptoms. In addition, there is a high risk of early in-stent restenosis, target vessel revascularization, stent fracture, perforation, and thrombosis [14, 15]. Additionally, cardiac surgeries, including coronary artery bypass grafting (CABG) and supra-arterial myotomy, appear to be more effective than percutaneous coronary intervention. Nevertheless, these procedures still face the risks of surgical trauma, graft occlusion, necrosis, and a higher late recurrence rate of angina [16, 17].
In this case, the patient had multiple consultations at different hospitals and was treated with β-blockers without symptom improvement. Based on the FFR, dFFR, ΔFFR, and ΔdFFR assessment results, a stent was implanted at the proximal fixed stenosis, resulting in a good prognosis and avoiding the risks associated with invasive treatment of MB. For patients with refractory symptoms, functional assessment is necessary when fixed stenosis is encountered with MB. It is noteworthy that ΔFFR and ΔdFFR can further clarify whether ischemia originates from MB, fixed stenosis, or their synergistic effect, thereby better informing clinical strategies. However, invasive FFR assessment faces challenges such as high economic costs, long procedural times, and adverse drug reactions.
Conclusion
In the clinic, MB accompanied by fixed stenosis is not uncommon. In this case, functional evaluation confirmed that neither of them could cause myocardial ischemia, but their synergistic effect resulted in myocardial ischemia. Therefore, for patients combined with MB and fixed stenosis, functional evaluation may be necessary, which has obvious guiding significance for the selection of treatment strategies.
Data availability
No datasets were generated or analysed during the current study.
Abbreviations
- MB:
-
Myocardial bridge
- LADp :
-
the proximal segment of the left anterior descending artery
- LADm :
-
the middle segment of the left anterior descending artery
- FFR:
-
Fractional flow reserve
- dFFR:
-
Diastolic fractional flow reserve
- ΔFFR:
-
Fractional flow reserve gradient
- ΔdFFR:
-
Diastolic fractional flow reserve gradient
- FFRa1 :
-
Fractional flow reserve value of coronary artery opening
- FFRa2 :
-
Fractional flow reserve value of proximal to the MB
- FFRa3 :
-
Fractional flow reserve value of distal to the MB
- dFFRa1 :
-
Diastolic fractional flow reserve value of coronary artery opening
- dFFRa2 :
-
Diastolic fractional flow reserve value of proximal to the MB
- dFFRa3 :
-
Diastolic fractional flow reserve value of distal to the MB
- FFRb1 :
-
Fractional flow reserve value of coronary artery opening after stent implantation
- FFRb2 :
-
Fractional flow reserve value of proximal to the MB after stent implantation
- FFRb3 :
-
Fractional flow reserve value of distal to the MB after stent implantation
- dFFRb1 :
-
Diastolic fractional flow reserve value of coronary artery opening after stent implantation
- dFFRb2 :
-
Diastolic fractional flow reserve value of proximal to the MB after stent implantation
- dFFRb3 :
-
Diastolic fractional flow reserve value of distal to the MB after stent implantation
- ΔFFR1 :
-
Fractional flow reserve gradient value through the stenosis
- ΔdFFR1 :
-
Fractional flow reserve gradient value through the MB
- ΔFFR2 :
-
Fractional flow reserve gradient value through the stenosis after stent implantation
- ΔdFFRa2 :
-
Fractional flow reserve gradient value through the MB after stent implantation
References
Montone RA, Gurgoglione FL, Del Buono MG et al. Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non-Obstructive Coronary Arteries: Pathogenic and Prognostic Implications. J Am Heart Assoc. 2021;10(14):e020535. https://doi.org/10.1161/JAHA.120.020535.
Pargaonkar V, Kimura T, Kameda R et al. Invasive assessment of myocardial bridging in patients with angina and no obstructive coronary artery disease. https://doi.org/10.4244/EIJ-D-20-00779.
Lin CC, Lai CH, Lin WS, Lin CS. Severe myocardial bridge presenting as paroxysmal atrioventricular block. J Postgrad Med. 2021;67(3):171–3. https://doi.org/10.4103/jpgm.JPGM_1027_20.
Nie C, Zhu C, Yang Q, Xiao M, Meng Y, Wang S. Myocardial bridging of the left anterior descending coronary artery as a risk factor for atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy: a matched case-control study. BMC Cardiovasc Disord. 2021;21(1):382. https://doi.org/10.1186/s12872-021-02185-1.
Hourmozdi JN, Schimmel D. Myocardial bridging. N Engl J Med. 2024;390(5):e11. https://doi.org/10.1056/NEJMicm2307383.
Aden D, Phulware RH, Mittal S, Ahuja A. Myocardial bridging - sudden unexpected death of a young girl: a case report. Indian J Pathol Microbiol. 2022;65(1):157–9. https://doi.org/10.4103/IJPM.IJPM_1177_20.
Matta A, Nader V, Canitrot R et al. Myocardial bridging is significantly associated to myocardial infarction with non-obstructive coronary arteries. Eur Heart J Acute Cardiovasc Care. 2022;11(6):501–7. https://doi.org/10.1093/ehjacc/zuac047.
Hostiuc S, Rusu MC, Hostiuc M, Negoi RI, Negoi I. Cardiovascular consequences of myocardial bridging: A meta-analysis and meta-regression. Sci Rep. 2017;7(1):14644. https://doi.org/10.1038/s41598-017-13958-0.
Roberts W, Charles SM, Ang C et al. Myocardial bridges: A meta-analysis. Clin Anat. 2021;34(5):685–709. https://doi.org/10.1002/ca.23697.
Sternheim D, Power DA, Samtani R, Kini A, Fuster V, Sharma S. Myocardial bridging: diagnosis, Functional Assessment, and management: JACC state-of-the-art review. J Am Coll Cardiol. 2021;78(22):2196–212. https://doi.org/10.1016/j.jacc.2021.09.859.
Matta A, Roncalli J, Carrié D. Update review on myocardial bridging: new insights. Trends Cardiovasc Med. 2024;34(1):10–5. https://doi.org/10.1016/j.tcm.2022.06.002.
Aleksandric SB, Djordjevic-Dikic AD, Dobric MR et al. Functional Assessment of Myocardial Bridging With Conventional and Diastolic Fractional Flow Reserve: Vasodilator Versus Inotropic Provocation. J Am Heart Assoc. 2021;10(13):e020597. https://doi.org/10.1161/JAHA.120.020597.
Ide T, Ohtani K, Higo T, Tanaka M, Kawasaki Y, Tsutsui H. Ivabradine for the Treatment of Cardiovascular Diseases. Circ J. 2019;83(2):252–60. https://doi.org/10.1253/circj.CJ-18-1184.
Ernst A, Bulum J, Šeparović Hanževački J, Lovrić Benčić M, Strozzi M. Five-year angiographic and clinical follow-up of patients with drug-eluting stent implantation for symptomatic myocardial bridging in absence of coronary atherosclerotic disease. J Invasive Cardiol. 2013;25(11):586–92.
Landrum EB, Schussler JM. Recurrent Stent Fracture Due to Myocardial Bridging: A Brief Report and Review of Published Cases. Am J Cardiol. 2023;200:75–7. https://doi.org/10.1016/j.amjcard.2023.05.016.
Hemmati P, Schaff HV, Dearani JA, Daly RC, Lahr BD, Lerman A. Clinical outcomes of Surgical Unroofing of Myocardial bridging in symptomatic patients. Ann Thorac Surg. 2020;109(2):452–7. https://doi.org/10.1016/j.athoracsur.2019.07.005.
Ji Q, Shen J, Xia L, Ding W, Wang C. Surgical treatment of symptomatic left anterior descending myocardial bridges: myotomy vs. bypass surgery. Surg Today. 2020;50(7):685–92. https://doi.org/10.1007/s00595-019-01935-1.
Acknowledgements
Not applicable.
Funding
This work was supported by the National Natural Science Foundation of China under Grant 2023-MSLH-127 and the Shenyang Science and Technology Bureau of China under Grant 22-321-33-49.
Author information
Authors and Affiliations
Contributions
Z. Q. and Q. F. and X.L. the conception and design of the work; H. L. , Z.R. and C.F. the acquisition and analysis of data; Z. Q. wrote original draft; Z. Q. and H. L. and Q. F. reviewed and edited the work; X. L. and Z.Q. prepared Figs. 1, 2 and 3; All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Consent for publication
Written informed consent to publish was obtained from the study participant.
Competing interests
The authors declare no competing interests.
Ethics approval and informed consent
The case was approved by the Medical Ethics Committee of The People’s Hospital of Liaoning Province.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supporting information_Video 1
: Coronary angiography showed moderate stenosis in LADp and MB in LADm
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Qin, Z., Lv, H., Ren, Z. et al. Myocardial ischemia caused by the synergistic effect of myocardial bridge and moderate stenosis: case report. BMC Cardiovasc Disord 24, 412 (2024). https://doi.org/10.1186/s12872-024-04069-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12872-024-04069-6